| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f52c68e4149a6c462b850d4e7cc2b2f9 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B32B33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 |
| filingDate |
2011-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_162326f7819ef0b1a9373bc6d3421036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_314cabe729bab08076aa17250a3ddb58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b52afc48d9398abc70fff2a6b606a05f |
| publicationDate |
2013-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201311452-A |
| titleOfInvention |
Transdermal therapeutic system with inhibiting crystalline protective film (release liner) |
| abstract |
The present invention relates to pharmaceutical formulations, particularly transdermal therapeutic systems, characterized in that the inactive active ingredient crystallizes out of the interface between the removable protective film (release liner) and the active ingredient-containing matrix. |
| priorityDate |
2011-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |